GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » Shiller PE Ratio

Hubei Guangji Pharmaceutical Co (SZSE:000952) Shiller PE Ratio : 40.86 (As of May. 11, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Hubei Guangji Pharmaceutical Co Shiller PE Ratio?

As of today (2025-05-11), Hubei Guangji Pharmaceutical Co's current share price is ¥5.72. Hubei Guangji Pharmaceutical Co's E10 for the quarter that ended in Mar. 2025 was ¥0.14. Hubei Guangji Pharmaceutical Co's Shiller PE Ratio for today is 40.86.

The historical rank and industry rank for Hubei Guangji Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SZSE:000952' s Shiller PE Ratio Range Over the Past 10 Years
Min: 33.07   Med: 100.25   Max: 549
Current: 40.86

During the past years, Hubei Guangji Pharmaceutical Co's highest Shiller PE Ratio was 549.00. The lowest was 33.07. And the median was 100.25.

SZSE:000952's Shiller PE Ratio is ranked worse than
76.29% of 523 companies
in the Drug Manufacturers industry
Industry Median: 24.47 vs SZSE:000952: 40.86

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hubei Guangji Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2025 was ¥-0.104. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.14 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hubei Guangji Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Hubei Guangji Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Guangji Pharmaceutical Co Shiller PE Ratio Chart

Hubei Guangji Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.13 60.27 41.41 55.50 42.71

Hubei Guangji Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.47 40.63 47.36 42.71 39.75

Competitive Comparison of Hubei Guangji Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Hubei Guangji Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Guangji Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Guangji Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hubei Guangji Pharmaceutical Co's Shiller PE Ratio falls into.


;
;

Hubei Guangji Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hubei Guangji Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=5.72/0.14
=40.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Guangji Pharmaceutical Co's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Hubei Guangji Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.104/115.1156*115.1156
=-0.104

Current CPI (Mar. 2025) = 115.1156.

Hubei Guangji Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 -0.052 99.500 -0.060
201509 0.008 100.500 0.009
201512 0.134 100.600 0.153
201603 0.077 102.200 0.087
201606 0.112 101.400 0.127
201609 0.225 102.400 0.253
201612 0.056 102.600 0.063
201703 0.081 103.200 0.090
201706 0.087 103.100 0.097
201709 0.103 104.100 0.114
201712 0.077 104.500 0.085
201803 0.281 105.300 0.307
201806 0.106 104.900 0.116
201809 0.051 106.600 0.055
201812 0.131 106.500 0.142
201903 0.102 107.700 0.109
201906 0.150 107.700 0.160
201909 0.135 109.800 0.142
201912 -0.056 111.200 -0.058
202003 -0.043 112.300 -0.044
202006 0.102 110.400 0.106
202009 0.086 111.700 0.089
202012 0.079 111.500 0.082
202103 0.056 112.662 0.057
202106 0.132 111.769 0.136
202109 0.042 112.215 0.043
202112 0.105 113.108 0.107
202203 0.024 114.335 0.024
202206 0.046 114.558 0.046
202209 -0.014 115.339 -0.014
202212 0.086 115.116 0.086
202303 -0.124 115.116 -0.124
202306 0.052 114.558 0.052
202309 -0.116 115.339 -0.116
202312 -0.207 114.781 -0.208
202403 -0.143 115.227 -0.143
202406 -0.159 114.781 -0.159
202409 -0.148 115.785 -0.147
202412 -0.389 114.893 -0.390
202503 -0.104 115.116 -0.104

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hubei Guangji Pharmaceutical Co  (SZSE:000952) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hubei Guangji Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Hubei Guangji Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Guangji Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 555, Huaihai West Road, 26th Floor, Xuhui District, Shanghai, CHN, 200030
Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.
Executives
Zou Guang Ming Independent director
Guo Shao Zhi Executives
Zhang Bin Director
Guo Wen Chao Supervisors
Sun Zhen Hua Director
Liao Qing Jiang Director
Wang Xin Directors, executives
Hu Feng Lei Supervisors
Ruan Zhong Yi Executives
Zhang Ping Director

Hubei Guangji Pharmaceutical Co Headlines

No Headlines